
Curanex Pharmaceuticals Inc — Investor Relations & Filings
Curanex Pharmaceuticals Inc. is a developmental-stage pharmaceutical company focused on the discovery, development, and commercialization of innovative botanical drugs. The company's primary efforts are directed towards creating treatments for patients suffering from inflammatory diseases, with a particular emphasis on developing therapies for moderate to severe ulcerative colitis. Its research platform has also validated effects in animal models for other inflammatory conditions, including atopic dermatitis and COVID-19.
Recent filings
| Filing | Released | Lang | Actions |
|---|---|---|---|
| 8-K | 2026-05-14 | English | |
| 10-Q | 2026-05-14 | English | |
| 8-K - Curanex Pharmaceuticals Inc (0002025942) (Filer) | 2026-05-07 | English | |
| 8-K - Curanex Pharmaceuticals Inc (0002025942) (Filer) | 2026-04-02 | English | |
| 10-K - Curanex Pharmaceuticals Inc (0002025942) (Filer) | 2026-03-30 | English | |
| 8-K | 2026-01-05 | English |
Browse filings by year
3 years| ID | Filing | Released | Lang | Actions | |
|---|---|---|---|---|---|
|
2026
6 filings
| |||||
| 46026259 | 8-K | 2026-05-14 | English | ||
| 46026352 | 10-Q | 2026-05-14 | English | ||
| 43150861 | 8-K - Curanex Pharmaceuticals Inc (0002025942) (Filer) | 2026-05-07 | English | ||
| 33155410 | 8-K - Curanex Pharmaceuticals Inc (0002025942) (Filer) | 2026-04-02 | English | ||
| 33093367 | 10-K - Curanex Pharmaceuticals Inc (0002025942) (Filer) | 2026-03-30 | English | ||
| 13706981 | 8-K | 2026-01-05 | English | ||
|
2025
9 filings
| |||||
| 13706982 | 10-Q | 2025-11-15 | English | ||
| 13706983 | NT 10-Q | 2025-11-15 | English | ||
| 13706984 | 8-K | 2025-11-06 | English | ||
| 13706985 | 8-K | 2025-09-29 | English | ||
| 13706986 | 8-K | 2025-09-12 | English | ||
| 13706987 | 10-Q | 2025-09-09 | English | ||
| 13706991 | 3 | 2025-09-03 | English | ||
| 13706988 | 3 | 2025-09-03 | English | ||
| 13706989 | 3 | 2025-09-03 | English | ||
Market data
Market data not available
Price history
Peer group · Manufacture of pharmaceuticals, medicinal chemical and botanical products
| Company | Ticker | Country | Sector |
|---|---|---|---|
|
BIOMARIN PHARMACEUTICAL INC
A global biotechnology company developing therapies for rar…
|
BMRN | US | Manufacturing |
|
BioMaxima S.A.
Manufacturer and distributor of in-vitro diagnostics for cl…
|
BMX | PL | Manufacturing |
|
Biomea Fusion, Inc.
A clinical-stage biopharma developing oral drugs for diabet…
|
BMEA | US | Manufacturing |
|
BIOME AUSTRALIA LIMITED
Develops and distributes evidence-based probiotics and comp…
|
BIO | AU | Manufacturing |
|
Biome Grow Inc.
Production and distribution of cannabis products focused on…
|
BIO | CA | Manufacturing |
|
BIOMERICA INC
Develops in-vitro diagnostic and therapeutic products for c…
|
BMRA | US | Manufacturing |
|
bioMérieux
A global leader in in vitro diagnostics for clinical and in…
|
BIM | FR | Manufacturing |
|
BIOMM SA
Develops and manufactures biopharmaceuticals and biosimilar…
|
— | BR | Manufacturing |
|
BiomX Inc.
Clinical-stage company developing phage therapies to target…
|
PHGE | US | Manufacturing |
|
BIONEERCORPORATION
Develops and manufactures molecular biology products for re…
|
064550 | KR | Manufacturing |
Curanex Pharmaceuticals Inc via the API
Pull this company's filings, identifiers, and metadata as JSON or Markdown. Authenticate with your API key, then query by company ID, ISIN, or LEI. Full schema documented in the OpenAPI spec.
Endpoints
| GET | /api/companies/34928/ | Company identity, sector, listing, identifiers |
| GET | /api/filings/?company=34928 | Paginated list of all filings (filterable by type, date, language) |
| GET | /api/filings/{id}/ | Single filing — metadata, document URL, processing status |
| GET | /api/filings/{id}/markdown/ | Filing content as Markdown (PDF → text/tables/figures) |
| GET | /api/isins/?company=34928 | All ISINs registered to this company |
| GET | /api/filing-types/ | Reference: every filing-type code + category |
cURL
$ curl https://api.financialreports.eu/api/filings/?company=34928 \ -H "x-api-key: $FR_API_KEY" \ -H "Accept: application/json"
Python
import requests r = requests.get( "https://api.financialreports.eu/api/filings/", params={"company": 34928}, headers={"x-api-key": API_KEY}, ) filings = r.json()["results"]
MCP server
// MCP server URL https://mcp.financialfilings.com/mcp // Once connected, the LLM can query this company directly: "Pull the latest 5 filings for Curanex Pharmaceuticals Inc (id: 34928)"
Report missing filing
Can't find a specific document? Let us know and we'll add it within 24 hours.